Xtant Medical to Issue Fourth Quarter and Full Year 2021 Financial Results on March 8, 2022
BELGRADE, Mont., March 01, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company...
Day: March 1, 2022
Allogene Therapeutics Publishes Inaugural Environmental, Social and Governance (ESG) Report
Comprehensive Report Highlights Efforts to Advance Diversity, Equity and Inclusion, Sustainable Business Practices, and Corporate GovernanceSOUTH SAN FRANCISCO, Calif., March...
Albireo Reports Q4 and Year-End 2021 Financial Results and Business Update
Bylvay™ (odevixibat) launched in the U.S. and Europe, 2021 product revenue, net $7 millionNICE endorses clinical and economic benefits of BylvayPhase...
Prometheus Biosciences to Participate at the Cowen 42nd Annual Healthcare Conference
SAN DIEGO, March 01, 2022 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision...
ProKidney to Present REACT® at 4th Annual CKD Summit
Presentation to include data on Mechanism of Action, clinical trials to-date and current regulatory statusWINSTON-SALEM, N.C., March 01, 2022 (GLOBE...
UPDATE — Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents
SAN DIEGO, March 01, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), and BICO (OTCPK: CLLKF, Nasdaq Stockholm: BICO.ST)...
Molecular Templates to Present at the Upcoming Investor Conferences
AUSTIN, Texas, March 01, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical...
Halberd’s COVID-19 Antibody is the Only One In Competitive Tests to Bind to Omicron Variant
Outperforms Approved COVID AntibodiesJackson Center, Pennsylvania--(Newsfile Corp. - March 1, 2022) - Halberd Corporation's (OTC Pink: HALB) previously developed SARS-CoV-2...
Red Light Holland Reports Fiscal Third Quarter Results
Company announces 28% increase in revenue and 48% increase in gross profit over the previous quarterNine-month revenues of $1,703,122Toronto, Ontario--(Newsfile...
Cardiol Therapeutics Receives Clearance from the FDA and Regulatory Agencies in Brazil and Mexico for Important Protocol Amendments Designed to Expedite Patient Enrollment in the LANCER Trial
LANCER Trial expanded to include up to 20 Additional Clinical Research CentersOakville, Ontario--(Newsfile Corp. - March 1, 2022) - Cardiol...
MEDITECH Expanse Ambulatory Now Available to Independent and Physician-Owned Practices
The solution’s web- and touch-based design offers a personalized user experience and efficient office workflows, without requiring an Expanse EHR...
Social Security Administration (SSA) Selects Veradigm eChart Courier™ to Automate Medical Chart Retrieval
Secure web services connection between SSA and Veradigm to reduce patient health record retrieval time from weeks or days to...
Establishment Labs Reports Fourth Quarter and Full Year 2021 Financial Results; Record Fourth Quarter Revenue of $35.3 Million
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and...
TriMas Announces Acquisition of Intertech
Further Expands TriMas’ Packaging Group into Medical End Market Applications BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--TriMas (NASDAQ: TRS) today announced that it...
LENSAR Announces U.S. Food and Drug Administration Acceptance of 510(k) Submission for ALLY
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser...
CureVac Establishes Fully-Owned Company Dedicated to Advancing The RNA Printer
∙ The RNA Printer® is CureVac’s integrated and automated manufacturing solution for RNA vaccines and therapeutics ∙ CureVac RNA Printer...
Model N Management to Present at the JMP Securities Technology Conference
SAN MATEO, Calif.--(BUSINESS WIRE)--Model N, Inc. (NYSE: MODN), the leader in cloud revenue management solutions, today announced that Jason Blessing,...
Evotec Expands Molecular Patient Database with Unique Nephrotic Syndrome Cohort from the University of Bristol
EVOTEC RECEIVES ACCESS TO AN INTERNATIONAL COHORT OF NEPHROTIC SYNDROME PATIENTS COORDINATED BY THE UNIVERSITY OF BRISTOLTHE COHORT PROVIDES LONGITUDINAL...